Measuring nasal mucus thickness in chronic rhinosinusitis with nasal polyps
Compares nasal mucus thickness in adults with chronic rhinosinusitis with nasal polyps and controls.
Key facts
- Who runs it
- University Hospital, Montpellier
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Polymorphonuclear Cells in the Middle Turbinate
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 1 May 2028
- Type of study
- Interventional
- Treatments tested
- Sinonasal sample collection and inflammatory assessment
- Record updated
- 13 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who need sinus and nose surgery. Some have chronic sinus swelling with nasal polyps (small growths in the nose), and some do not, as a comparison group.
- Age
- 18 Years to 85 Years
- Sex
- All sexes can join.
- Disease stage
- For the polyp group: nasal polyps seen in both sides of the nose with a camera exam. Also 2 or more symptoms for at least 12 weeks, such as blocked nose, runny nose, facial pain or pressure, or reduced or lost sense of smell.
- Earlier treatment
- People must need sinus and nose surgery.
Main reasons for not taking part
- Not able to give a nose mucus sample by blowing the nose
- Nasal polyps caused by another disease, such as cystic fibrosis, ciliary dyskinesia, immune disorders or allergic fungal sinusitis
- Not able to read or write
- Under legal guardianship or curatorship, or held by a court or administrative decision
- No social security coverage
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patient requiring sinonasal surgery
- For patients in the CRSwNP group:; Presence of nasal polyposis defined according to EPOS 2020 recommendations:; Clinical examination revealing, for at least 12 weeks prior to inclusion, 2 or more of the following symptoms:
- Nasal congestion
- Rhinorrhea (anterior/posterior)
- Or a Facial pain/pressure
- Or a Reduced or lost sense of smell AND visible polyps in both nasal cavities on endoscopic examination of the middle meatus (regardless of size)
Who cannot take part
- Inability to provide a sinonasal secretion sample by blowing; Conditions causing secondary nasal polyposis (e.g., cystic fibrosis, ciliary dyskinesia, immune disorders, allergic fungal sinusitis); Illiteracy; Lack of consent; Legal protection status (guardianship, curatorship, etc.); No social security coverage; Persons deprived of liberty by judicial or administrative decision; Participation in another study with an ongoing exclusion period
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This monocentric, interventional study (category RIPH2) aims to characterize the rheological properties of sinonasal secretions in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). The primary objective is to determine differences in mucus viscosity between CRSwNP patients and a control group. By establishing a correlation between local rheology and systemic Type 2 inflammation biomarkers, the study seeks to develop a non-invasive, rapid "point-of-care" tool to refine patient phenotyping and improve the personalization of biological treatments.
The group in the trial
- Characterize and compare patients with and without CRSwNPTreatment being tested
Experimental: Characterize and compare patients with and without CRSwNP Assessment of rheological and inflammatory variables
Treatment: Sinonasal sample collection and inflammatory assessment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Polymorphonuclear Cells in the Middle Turbinate
- Plain-language title
- Measuring nasal mucus thickness in chronic rhinosinusitis with nasal polypsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT07524127, who can take part
- Record updated
- 13 April 2026